Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: Effect of the anti-inflammatory compound L-mimosine

International Journal of Immunopathology and Pharmacology

Volumn 18, Issue 1, 2005, Pages 85-93

  Frydas, S ^a   Papaioannou, N ^a   Papazahariadou, M ^a   Hatzistilianou, M ^a   Karagouni, E ^b   Trakatelli, M ^a   Brellou, G ^a   Petrarca, C ^c   Castellani, M L ^c   Conti, P ^c   Riccioni, G ^c   Patruno, A ^c   Grilli, A ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Anti inflammatory compound; L mimosine; MCP 1; MIP 2; Trichinellosis

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; MIMOSINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DNA REPLICATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; HISTOPATHOLOGY; LYMPHOCYTE; MACROPHAGE; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TRICHINELLA SPIRALIS; TRICHINOSIS;

EID: 20044366358     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800110     Document Type: Article

References (60)

1. Wang G., R. Miskimins and W.K. Miskimins. 2000. Mimosine arrests cells in G1 by enhancing the levels of p27 (Kipl). Exp. Cell. Res. 254:64.
2. Mosca P.J., P.A. Dijkwel and J.L. Hamlin. 1993. The plant amino acid mimosine may inhibit initiation at origins of replication in Chinese hamster cells. Mol. Cell. Biol. 12:4375.
3. Chang H.C., C.F. Weing, M.H. Yen, et al. 2000. Modulation of cell cycle regulatory protein expression and suppression of tumor growth by mimosine in nude mice. Int. J. Oncol. 17:659.
4. Lalande M. 1990. A reversible arrest point in the late G1 phase of the mammalian cell cycle. Exp. Cell. Res. 186:332.
5. Lin H.B., R. Falchetto, P.J. Mosca, et al. 1996. Mimosine targets serine hydromethyltransferase. J. Biol. Chem. 271:2548.
6. Baggiolini M. and C.A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunol. Today 15:127.
7. Oppenheim J.J., C.O.O Zacharie, N. Mukaida and K. Matsushima. 1991. Properties of the novel proinflammatory supergene "Intercrine" cytokine family. Ann. Rev. Immunol. 9:617.
8. Matsushima K., K. Morishima, T. Yoshimura, et al. 1988. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor. J. Exp. Med. 167:1883.
9. Sharafeldin A., R. Eltayeb, M. Pashenkov and M. Bakhiet. 2000. Chemokines are produced in the brain early during the course of experimental African trypanosomiasis. J. Neuroimmunol. 103:165.
10. Kalyanaraman M., S.M. Heidemann and A.R. Sarnaik. 1998. Macrophage inflammatory protein-2 predicts acute lung injury in endotoxemia. J. Invest. Med. 46:275.
11. Yoshidome H., A.B. Lentsch, et al. 1999. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice. J. Surg. Res. 81:33.
12. Schall T.T. 1991. Biology of the RANTES/SIS cytokine family. Cytokine 3:165.
13. Conti P., R.C. Barbacane and M. Reale. 1999. Chemokines in inflammatory states. Allergy Asthma Proc. 20:205.
14. Carr M.W., S.T. Roth, E. Luther, S.S. Rose and T.A. Springer 1994. Monocyte chemoattractant protein-1 acts as a T-Lymphocyte chemoattractant. Proc. Natl. Acad. Sci. (USA) 91:3652.
15. Ali Khan Z. 1996. The postembryonic development of Trichinella spiralis with special reference to endysis. J. Parasitol. 52:248.
16. Soulsby E.L. 1968. The aphasmid nematodes. In Helminth anthropodes and protozoa of domesticated animals, ed. Williams and Wilns Co Baltimore, p. 314.
17. Haralabidis S., M. Daoudaki and S. Fridas. 1993. T cell subpopulations and IL-6, IL-10, TNF-alpha and specific immunoglobulin levels in murine Trichinellosis. Int. J. Immunopathol. Pharmacol. 10:23.
18. Frydas S., E. Karagouni, E. Dotsika, et al. 1996. Generation of TNF-α, IFN-γ, IL-6, IL-4 and IL-10 in mouse serum from trichinellosis: Effect of the anti-inflammatory compound 4-deoxypyridoxine (4-DPD). Immun. Lett. 49:179.
19. Conti P., S. Frydas, M. Reale, et al. 2002. Inhibition of MCP-1 and MIP-2 transcription and translation by mimosine in muscle tissue infected with the parasite Trichinella spiralis. Mol. Cell. Biochem. 229:129.
20. Van Zutphen L.F.M., V. Baumans and A.C. Beymen. 2001. Principles of laboratory animal science. In A contribution to the human use and care of animals and to the quality of experimental results, ed. Elsevier Amsterdam, p.1.
21. Gilbert D.M., A. Neilson, H. Miyazawa, et al. 1995. Mimosine arrests DNA synthesis at replication forks by inhibiting deoxyribonucleotide metabolism. J. Biol. Chem. 270:9597.
22. Polacino P.S., L.M. Pinchuk, S.P. Sidorenko and E.A. Clark. 1996. Immunodeficiency virus cDNA synthesis in resting T lympocytes is regulated by T cell activation signals and dendritic cells. J. Med. Primatol. 25:201.
23. Watson P.A., H.H. Hanauske, A. Flint and M. Lalande. 1991. Mimosine reversibly arrests cell cycle progression at the G1-S phase border. Cytometry 12:242.
24. Ju H., J. Hao, S. Zhao and I.M.C. Dixon. 1998. Antiproliferative and antifibriotic effects of mimosine on adult cardiac fibroblasts. Biochem. Biophys. Acta 1448:51.
25. Haralabidis S., S. Fridas, E. Karagouni and C. Himonas. 1992. Trichinells spiralis-Ab3 (IgG, IgM, IgA) IL-6 and TNF levels in murine Trichinellosis. Int. J. Immunopath. Pharmacol. 5:173.
26. Robert M., I. Matossian, A. Salti and E. Stephan. 1977. Variation in serum immunoglobulin levels in acute te trichinellosis. J. Helm. 51:1.
27. Roitt I.M. 1988. In Essential Immunology-Immunity to parasite infection. Blackwell Scientific Publications Oxford U.K., p. 164.
28. Goyal P.K., J. Hermanek and D. Wakelin. 1994. Lymphocyte proliferation in mice infected with different geographical isolates of Trichinella spiralis. Parasite Immunol. 16:105.
29. Grencis R.K., L. Hultner and K.J. Else. 1991. Host protective immunity to Trichinella spiralis in mice: activation of Th cell subsets and lymphokine secretion in mice expressing different response phenotypes. Immunol. 74:329.
30. Dai Y., B. Gold, J.K. Vishwanatha and S.L. Rhode. 1994. Mimosine inhibits viral DNA synthesis through ribonucleotide reductase. Virol. 205:210.
31. Ransohoff R.M., A. Glabinki and M. Tani. 1996. Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev. 7:35.
32. Taub D., J. Dastych and N. Inamura. 1995. Bone marrow-derived murine mast cells migrate, but do not degranulate in response to chemokines. J. Immunol. 154:2393.
33. Wang Y., J. Zhao, J. Clapper, et al. 1995. Mimosine differentially inhibits DNA replication and cell cycle progression in somatic cells compared to embryonic cells of Xenopus laevis. Exp: Cell. Res. 217:84.
34. Farinelli S.E. and L.A.L. Greene. 1996. Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmimotic sympatyhetic neurons after removal of trophic support. J. Neurosci. 16:1150.
35. Kalejta R.F. and T.L. Hamlin. 1997. The dual effect of mimosine on DNA replication. Exp. Cell Res. 23:173.
36. Trakatelli M. 1999. The activity of serine-hydromethyltransferase (SHMT) as marker of cellstatic and immunosuppresor action of different substances. In Thesis, ed. Aristotle University of Thessaloniki Greece, p.1.
37. Kelly E.A.B., S.C. Enderson, K.M. Handa and D.L. Wassom. 1991. INF-γ and IL-5 producing cells compartmentalize to different lymphoid organs in Trichinella spiralis infected mice. J. Immunol. 147:306.
38. Abbas A.K., A.H. Lichtman and J.S. Robert. 1991. Cellular and molecular immunology. In Effector cells of call-mediated immunity, ed. W.B. Saunders Co. Philadelphia, p.250.
39. Luster A.D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. New Engl. J. Med. 338:436.
40. Frydas S., T. Rallis, I. Theodoridis, et al. 2000. Trichinella spiralis infection is mediated by MCP-1 and MIP-2, while Echinococcus grannlosus is mediated strongly by MCP-1, but not MIP-2. Int. J. Immunopathol. Pharmacol. 13:21.
41. Rennick D., G. Yang, C. Muller-Sieburg, et al. 1987. Interleukin-4 (B-cell stimulatory factor-1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells. Proc. Natl. Acad. Sci. USA 84: 6889.
42. Favre C., S. Saeland, C. Caux, V. Duvert and J.E. De Vries. 1990. Interleukin-4 has basophilic and eosinophilic cell growth-promoting activity on cord blood cells. Blood 75:67.
43. Kempuraj D., J. Donelan, S. Frydas, et al. 2004. Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities. Int. J. Immunopathol. Pharmacol. 17:103.
44. Cross M.L. 2004. Immune-signalling by orally-delivered probiotic bacteria: effects on common mucosal immunoresponses and protection at distal mucosal sites. Int. J. Immunopathol. Pharmacol. 17:127.
45. Kempuraj D., B. Madhappan, R. Sheeladevi, et al. 2004. T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors. Int. J. Immunopathol. Pharmacol. 17:57.
46. 4 and serum amyloid A elicit opposite interleukin-8 and NF-κB responses via the common ALX receptor. Int. J. Immunopathol. Pharmacol. 17:145.
47. Pannellini T., M. Iezzi, E. Di Carlo, et al. 2004. The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. Int. J. Immunopathol. Pharmacol. 17:171.
48. + T cells and monocytes after ischemia/reperfusion in patients undergoing primary percutaneous revascularization. Int. J. Immunopathol. Pharmacol. 17:165.
49. Hitoglou S., S. Frydas, M. Hatzistilianou, et al. 2004. Response of ADA and its isoenzymes in mice infected by Trichinella spiralis and treated with mimosine. Int. J. Immunopathol. Pharmacol. 17:191.
50. Vojdani A., J. B. Pangborn, E. Vojdani and E.L. Cooper. 2003. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int. J. Immunopathol. Pharmacol. 16:189.
51. Bogdanos D. P., M. Lenzi, M. Okamoto, et al. 2004. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA b51. Int. J. Immunopathol. Pharmacol. 17:83.
52. Battistoni A., M. Ajello, S. Ammendola, et al. 2004. Involvement of reactive oxygen species in bacterial killing within epithelial cells. Int. J. Immunopathol. Pharmacol. 17:71.
53. 4). Int. J. Immunopathol. Pharmacol. 16:99.
54. Santino I., A. Iori, M. Nicoletti, et al. 2003. Prevalence of Borrelia burgdorferi sensu lato genomospecies and of the human granulocitic ehrlichiosis (HGE) agent in Ixodes ricinus ticks collected in the area of Monti Lepini, Italy. Int. J. Immunopathol. Pharmacol. 16:105.
55. Kempuraj D., S. Frydas, K. Kandere, et al. 2003. Interleukin-19 (IL-19) network revisited. Int. J. Immunopathol. Pharmacol. 16:95.
56. E. Camera, S. Lisby, M.L. Dell'Anna, et al. 2003. Mononuclear cell antioxidant pattern and skin reactivity to irritants. Int. J. Immunopathol. Pharmacol. 16:49.
57. Frydas S., B. Madhappan and D. Kempuraj, 2002. Some aspects of parasitology and immunology in general medicine. Int. J. Immunopathol. Pharmacol. 15:165.
58. Austen W.G. Jr., L. Kobzik, M.C. Carroll, et al. 2003. The role of complement and natural antibody in intestinal ischemia-reperfusion injury. Int. J. Immunopathol. Pharmacol. 16:1.
59. A. Romano, C. Mondino, M. Viola and P. Montuschi. 2003. Immediate allergic reactions to β-lactams: diagnosis and therapy. Int. J. Immunopathol. Pharmacol. 16:19.
60. G. Bruno, F. Tega, A. Bruno, et al. 2003. The role of substance P in the cerebral ischemia. Int. J. Immunopathol. Pharmacol. 16:67.